| JAKAFI XR |
217180 |
001 |
NDA |
RUXOLITINIB PHOSPHATE |
TABLET, EXTENDED RELEASE;ORAL |
EQ 11MG BASE |
Yes
|
No
|
2026/05/01
|
--
|
INCYTE CORP |
Prescription |
| JAKAFI XR |
217180 |
002 |
NDA |
RUXOLITINIB PHOSPHATE |
TABLET, EXTENDED RELEASE;ORAL |
EQ 22MG BASE |
Yes
|
No
|
2026/05/01
|
--
|
INCYTE CORP |
Prescription |
| JAKAFI XR |
217180 |
003 |
NDA |
RUXOLITINIB PHOSPHATE |
TABLET, EXTENDED RELEASE;ORAL |
EQ 33MG BASE |
Yes
|
No
|
2026/05/01
|
--
|
INCYTE CORP |
Prescription |
| JAKAFI XR |
217180 |
004 |
NDA |
RUXOLITINIB PHOSPHATE |
TABLET, EXTENDED RELEASE;ORAL |
EQ 44MG BASE |
Yes
|
No
|
2026/05/01
|
--
|
INCYTE CORP |
Prescription |
| JAKAFI XR |
217180 |
005 |
NDA |
RUXOLITINIB PHOSPHATE |
TABLET, EXTENDED RELEASE;ORAL |
EQ 55MG BASE |
Yes
|
Yes
|
2026/05/01
|
--
|
INCYTE CORP |
Prescription |